Re: Thoughts on ZCC
in response to
by
posted on
Sep 04, 2021 10:22AM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
ZCC and Constellation Pharmaceuticals. Why the valuation difference? A valid question, but a different one. I'm just looking at the reality of where we are. With the stock where it is, the PPs look pretty good to me.